96 filings
6-K
ADAG
Adagene Inc
29 Mar 24
Current report (foreign)
3:36pm
424B5
ADAG
Adagene Inc
29 Mar 24
Prospectus supplement for primary offering
3:33pm
20-F
2023 FY
ADAG
Adagene Inc
Annual report (foreign)
29 Mar 24
2:53pm
6-K
ADAG
Adagene Inc
29 Mar 24
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
9:00am
6-K
ADAG
Adagene Inc
9 Feb 24
Current report (foreign)
6:08am
6-K
cfxxok
16 Jan 24
Current report (foreign)
5:00pm
6-K
ekkr7800upwz3go
3 Nov 23
Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 at SITC 2023
12:00pm
6-K
owck9jp
29 Sep 23
Current report (foreign)
6:30am
6-K
wo6a 72riv4r6
31 Aug 23
Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
7:00am
UPLOAD
sf1jftw9ovb j4c5hkjw
11 Jul 23
Letter from SEC
12:00am
CORRESP
khsm6
10 Jul 23
Correspondence with SEC
12:00am
6-K
3reu35qzq twrel8i0l
7 Jul 23
Unleashing Anti - CTLA - 4 Therapy By Enhancing the Therapeutic Index July 2023
4:34pm
CORRESP
3tas584g
16 Jun 23
Correspondence with SEC
12:00am
UPLOAD
yjt8ceg1fqz717ny6u
5 Jun 23
Letter from SEC
12:00am
6-K
481tvmbjg2oov6cknm0
4 May 23
Current report (foreign)
9:00am
6-K
btit8
28 Apr 23
Adagene Announces Updates to its Board of Directors
7:04am
6-K
uob lij0jtb2zs
18 Apr 23
Current report (foreign)
9:26am
6-K
iiy84z42ej47 ddl48
28 Mar 23
Adagene Reports Full Year 2022 Financial Results and Provides Corporate Update
5:06pm
6-K
sdxc46fiwfnlm
9 Jan 23
Current report (foreign)
7:00am